29 results on '"Thiebaut-Bertrand A"'
Search Results
2. Nilotinib with or without cytarabine for Philadelphia-positive acute lymphoblastic leukemia
3. Genetic alterations and MRD refine risk assessment for KMT2A-rearranged B-cell precursor ALL in adults: a GRAALL study
4. Efficacy and tolerance of brexucabtagene autoleucel in adults with R/R B-ALL: a GRAALL study from the DESCAR-T registry
5. Virus d’Epstein-Barr et syndromes lymphoprolifératifs post-transplantation
6. Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma
7. Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma
8. Early picc-line infections in non-neutropenic patients are mainly due to E. coli suggesting that third-generation cephalosporin may be used as a first-line antibiotic therapy
9. En-suite bathrooms in protected haematology wards: a source of filamentous fungal contamination?
10. Comment on ‘Therapeutic drug monitoring-guided treatment versus standard dosing of voriconazole for invasive aspergillosis in haematological patients: A multicentre, prospective, cluster randomised, crossover clinical trial’
11. Upfront Allogeneic Stem Cell Transplantation after Reduced-Intensity/Nonmyeloablative Conditioning for Patients with Myelodysplastic Syndrome: A Study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire
12. Blinatumomab during Consolidation in High-Risk Philadelphia Chromosome (Ph)-Negative B-Cell Precursor (BCP) Acute Lymphoblastic Leukemia (ALL) Adult Patients: A Two-Cohort Comparison within the Graall-2014/B Study
13. In Adults with Ph-Negative Acute Lymphoblastic Leukemia (ALL), Age-Adapted Chemotherapy Intensity and MRD-Driven Transplant Indication Significantly Reduces Treatment-Related Mortality (TRM) and Improves Overall Survival - Results from the Graall-2014 Trial
14. Seven-year surveillance of nosocomial invasive aspergillosis in a French University Hospital
15. Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients
16. Community-acquired invasive aspergillosis and outdoor filamentous fungal spore load: a relationship?
17. Frontline Consolidation with Blinatumomab for High-Risk Philadelphia-Negative Acute Lymphoblastic Adult Patients. Early Results from the Graall-2014-QUEST Phase 2
18. The Omission of High-Dose Cytarabine during Consolidation Therapy of Ph-Positive ALL Patients Treated with Nilotinib and Low-Intensity Chemotherapy Results in an Increased Risk of Relapses Despite Non-Inferior Levels of Late BCR-ABL1 MRD Response. First Results of the Randomized Graaph-2014 Study
19. Alemtuzumab for Severe Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease
20. Sensitive Monitoring of BCR-ABL1 Kinase Domain Mutations By Next Generation Sequencing for Optimizing Clinical Decisions in Philadelphia-Positive Acute Lymphoblastic Leukemia in the Graaph-2014 Trial
21. Risk Factors of BK Virus Cystitis in Haematopoietic Stem Cell Transplantation-a Retrospective Monocentric Study
22. Invasive aspergillosis: drug-dispensing systems as a source of filamentous fungal contamination in high-risk units?
23. Apport du séquençage nouvelle génération au typage MLST de Pneumocysits jirovecii, dans le cadre d’une épidémie chez des patients transplantés d’organe solide
24. Intérêt de la quantification des pseudo corps de Howell-Jolly dans les polynucléaires neutrophiles par l’analyseur CellaVision DM96 pour le diagnostic des toxicités hématologiques du ganciclovir
25. Nivolumab Is Effective and Reasonably Safe in Relapsed or Refractory Hodgkin's Lymphoma after Allogeneic Hematopoietic Cell Transplantation: A Study from the Lysa and SFGM-TC
26. The contribution of a simple bioassay in effective therapeutic drug monitoring of Posaconazole and Voriconazole
27. Influence of Preexisting Invasive Aspergillosis on Allo-HSCT Outcome: A Retrospective EBMT Analysis from the Infectious Diseases and Acute Leukemia Working Parties
28. Évaluation de l’antigénémie Candida dans le diagnostic biologique de la candidose chez les patients hospitalises au CHU de Grenoble
29. Surveillance de la sensibilité de Candida krusei à l’amphotéricine B de 2003 à 2011 au CHU de Grenoble
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.